🕒 Last update: loading…

Stock Omega Healthcare Investors, Inc. OHI

Omega Healthcare Investors, Inc. — Investlytic score 2/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 17/09/2026.

  • ❌ Price trend failed
  • ✅ Growth passed
  • ❌ Debt failed
  • ✅ P/E passed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 20.48%

Price change 2019 → 2020: -14.24%

Price change 2020 → 2021: -18.53%

Price change 2021 → 2022: -5.54%

Price change 2022 → 2023: 9.70%

Price change 2023 → 2024: 23.45%

Price change 2024 → 2025: 17.15%

Price change 2025 → 2026: 14.19%

Price change 2026 (year to date): 13.70%

Financial growth

Revenue CAGR (8 years): 4.48%

Earnings CAGR (8 years): 11.15%

Growth status: positive trend (>1%/yr) in revenue and earnings.

Debt

Debt-to-equity ratio: 0.82

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 15.60

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 2.11% from the high over 6 months.

Insufficient correction (< 10.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, mechanical verdict of the method (hold, watch, sell: the same for all) and the detail of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Omega Healthcare Investors, Inc.16.10.82+10.8 %🔒
Unibail-Rodamco-Westfield SE8.21.38+4.9 %–
Healthpeak Properties, Inc.57.11.39+3.7 %–
Vonovia SE3.81.58+10.2 %–
Klépierre7.80.94+4.7 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Omega Healthcare Investors, Inc. over the latest fiscal years.

Revenue
1.2 bn USD
fiscal year 2025
Net income
590 m USD
fiscal year 2025
Net margin
49.2 %
fiscal year 2025
Average annual growth
+6.1 %
Revenue growth over 5 years
Average annual growth
+4.9 %
Revenue growth over 10 years
Market cap
14.3 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
2020892 m159 m17.9 %n/a
20211.1 bn417 m39.2 %+19.1 %
2022878 m427 m48.6 %-17.4 %
2023950 m242 m25.5 %+8.1 %
20241.1 bn406 m38.6 %+10.7 %
20251.2 bn590 m49.2 %+14.0 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Omega Healthcare Investors, Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
average accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
1.94
gray zone (1.81 to 2.99)
Piotroski Score
6 / 9
4 to 6: average accounts
DCF Value
92.16 USD
DCF above share price · share price 47.33 USD, gap +94.7 %
Net Debt / EBITDA
2.88 x
moderate debt
Fiscal year20212022202320242025
Cash and investments20.5 m297 m443 m518 m27.0 m
Total Debt5.3 bn5.3 bn5.1 bn4.8 bn4.3 bn
Net Debt5.2 bn5.0 bn4.6 bn4.3 bn4.2 bn
Equity3.9 bn3.6 bn3.6 bn4.5 bn5.2 bn
Total assets9.6 bn9.4 bn9.1 bn9.9 bn10.0 bn
Operating cash flow722 m626 m627 m749 m879 m
Investments (capex)95.1 m47.2 m38.0 m37.8 m0
Free cash-flow627 m579 m589 m713 m879 m
Share buybacks0142 m000
Dividends paid638 m633 m644 m685 m780 m

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)18.59 x
Price / book value2.60 x
Return on Equity (ROE)14.3 %
Return on Invested Capital (ROIC)7.2 %
Net margin57.7 %
Debt / equity0.73 x
Current ratio1.48 x
Interest coverage3.71 x
Free cash-flow yield5.6 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.

+

Valuation and competitors

Omega Healthcare Investors, Inc. compared with its sector on the same exchange and with its main competitors.

Company P/E
16.1
63.6 % below the sector
Sector median P/E
44.1
real estate, NYSE
Sector over 10 years
42.7
10-year median, range 32.2 to 55.6

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 11/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Omega Healthcare Investors, Inc. publish: ratings, price targets and earnings forecasts.

Majority rating
hold
29 analysts
Average price target
49.88 USD
from 46.00 USD to 56.00 USD, 23 targets over 12 months
Gap with the share price
+3.5 %
price 48.19 USD on 06/11/2026

Breakdown of ratings

strong buy 0buy 8hold 18sell 3strong sell 0

Analysts' average target 49.88 USD, DCF value 92.16 USD, share price 48.19 USD.

Average target over the last 3 months: 49.86 USD (7 targets).

Analyst forecasts

Fiscal yearRevenueNet incomeExpected EPS (range)P/E on this EPSAnalysts
20261.1 bn806 m2.65 (2.55 / 2.71)18.23
20271.2 bn629 m2.02 (1.98 / 2.07)23.94
20281.3 bn644 m2.07 (2.05 / 2.09)23.32

Amounts in USD, the reporting currency.

Track record against expectations: reported EPS above consensus 6 times over the last 12 releases.

Rating changes (12 months)

DateFirmBeforeAfter
11/11/2026UBSBuyBuy
22/10/2026CitizensMarket PerformMarket Outperform
19/10/2026Wells FargoEqual WeightEqual Weight
13/10/2026UBSBuyBuy
13/10/2026BarclaysUnderweightUnderweight

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Omega Healthcare Investors, Inc.

Large funds tracked
22
hold the stock as of 2026Q2

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Vanguard Group42.2 m1.9 bn0.0 %0.0 %2025Q4
BlackRock38.6 m1.8 bn0.0 %+3.6 %2026Q2
State Street29.1 m1.4 bn0.0 %+99.4 %2026Q2
Geode Capital Management9.1 m436 m0.0 %+2.4 %2026Q2
Invesco5.9 m281 m0.0 %-0.6 %2026Q2
Norges Bank4.0 m190 m0.0 %+13.3 %2026Q2
Northern Trust3.3 m157 m0.0 %+5.6 %2026Q2
Morgan Stanley2.9 m138 m0.0 %-13.1 %2026Q2

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 07/08/1992
ISIN code
US6819361006
Workforce
60
full-time employees
Chief executive
C. Taylor Pickett CPA
Next earnings
03/02/2027

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Omega Healthcare Investors, Inc.

What is the Omega Healthcare Investors, Inc. share price?

Latest recorded price: 47.05 USD on 13/11/2026, for a market cap of 14.3 bn USD.

What is the revenue of Omega Healthcare Investors, Inc.?

1.2 bn USD for fiscal year 2025, with net income of 590 m USD (net margin 49.2 %).

When does Omega Healthcare Investors, Inc. report its next earnings?

The next release is expected on 03/02/2027. EPS expected by analysts: 0.51.

What do analysts say about Omega Healthcare Investors, Inc.?

Out of 29 analysts: 8 buy or strong buy, 18 hold, 3 sell or strong sell. Average price target: 49.88 USD, i.e. +3.5 % from the share price.

What is the P/E ratio of Omega Healthcare Investors, Inc.?

Trailing 12-month P/E of 16.1, against 44.1 for the sector median on the same exchange (10-year median: 42.7).

Is Omega Healthcare Investors, Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US6819361006).

How many employees does Omega Healthcare Investors, Inc. have?

60 full-time employees according to the latest published profile.

Who runs Omega Healthcare Investors, Inc.?

C. Taylor Pickett CPA is the company's chief executive.

Which large funds own Omega Healthcare Investors, Inc.?

As of 2026Q2, among the large funds tracked: Vanguard Group, BlackRock, State Street, Geode Capital Management, Invesco.

07

Similar stocks